about
Classifying unknowns: the idiopathic problem.May Measurement Month 2017: an analysis of blood pressure screening results worldwideMay Measurement Month 2017: an analysis of blood pressure screening results in Armenia-EuropeMay Measurement Month 2017: an analysis of the blood pressure screening campaign results in Pakistan-South AsiaBlood pressure screening during the May Measurement Month 2017 programme in Vietnam-South-East Asia and AustralasiaMay Measurement Month 2017: Blood pressure screening results from Zambia-Sub-Saharan AfricaMay Measurement Month 2017 in Russia: hypertension treatment and control-EuropeMay Measurement Month 2017: analysis of the blood pressure screening results in Argentina-AmericasMay Measurement Month 2017: Brazilian results-AmericasMay Measurement Month 2017: Results from Taiwan-East AsiaMay Measurement Month 2017: an analysis of the blood pressure screening campaign results in India-South AsiaResults of the May Measurement Month 2017: blood pressure campaign in Venezuela-AmericasMay Measurement Month 2017: an analysis of the blood pressure screening campaign results in Indonesia-South-East Asia and AustralasiaMay Measurement Month 2017 blood pressure screening: findings from Malaysia-South-East Asia and AustralasiaMay Measurement Month 2017: an analysis of blood pressure screening in the Philippines-South-East Asia and AustralasiaMay Measurement Month 2017 in Chile-AmericasMay Measurement Month 2017: analysis of the blood pressure screening results in Ecuador-AmericasMay Measurement Month 2017: the results of blood pressure screening of 14 845 individuals in Kenya-Sub-Saharan AfricaMay Measurement Month 2017: an analysis of blood pressure screening results in Colombia-AmericasMay Measurement Month 2017: an analysis of blood pressure screening results from the United Arab Emirates-Northern Africa and Middle EastNation-wide hypertension screening in Italy: data from May Measurements Month 2017-EuropeMay Measurement Month 2017: an analysis of blood pressure screening results in Nepal-South AsiaMay Measurement Month 2017: an analysis of blood pressure screening results in Cote d'Ivoire-Sub-Saharan AfricaMay Measurement Month 2017: an analysis of blood pressure screening results in China-East AsiaMMM17-Cameroon, analysis and opportunities-Sub-Saharan AfricaMay Measurement Month 2017: an analysis of blood pressure screening results in Austria-EuropeDo we know more about hypertension in Poland after the May Measurement Month 2017?-EuropeMay Measurement Month 2017: an analysis of blood pressure screening in Spain-EuropeMay Measurement Month 2017: an analysis of blood pressure screening in Angola-Sub-Saharan AfricaMay Measurement Month 2017: an analysis of blood pressure screening in Hungary-EuropeMay Measurement Month 2017: results of a blood pressure screening campaign in Malawi-Sub-Saharan AfricaMay Measurement Month 2017: an analysis of blood pressure screening results in Georgia-EuropeMay Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and AustralasiaMay Measurement Month 2017: an analysis of blood pressure screening in Sudan-Northern Africa and Middle EastMay Measurement Month (MMM) 2017: an analysis of blood pressure screening results in Bangladesh-South AsiaMay Measurement Month 2017: an analysis of blood pressure screening results from the United Kingdom and the Republic of Ireland-EuropeMay Measurement Month 2017: Results from Cabo Verde-Sub-Saharan AfricaRates of untreated, treated, and controlled hypertension and relationships between blood pressure with other cardiovascular risk factors in Brazzaville (Republic of the Congo): May Measurement Month 2017-Sub-Saharan AfricaReduced Rates of Severe Complications Following a Change in Anthracycline-Taxane Regimen for Early Breast Cancer: a Single Centre ExperienceMay measurement month 2017: Latin America
P50
Q39459459-332F17A3-F845-45C9-83F3-056CEF9F27FAQ57485763-0C50C9C6-0849-4970-9125-677D743B601FQ64092447-2A5FC019-DFA9-46B3-801B-03C8B50E04A0Q64092451-C6D6C2AF-1C0E-47CE-A807-B3C7C822DF58Q64092456-D6841401-1CDD-40A2-A312-708E4A99995EQ64092459-90771E3B-B900-4531-B054-C2FB8BFA412EQ64092461-A1EF93CA-2F45-4041-A359-07D230D76187Q64092464-4B7C5DE6-8B1D-4351-89FD-1F6004B8322BQ64092468-43F63DD0-349B-4030-967F-6A0C512CBC12Q64092470-B7E76E24-C4E3-4989-9E46-88438C58A10CQ64092473-7E3CDBF3-1382-4CDE-97A4-8A5C9D3B7A66Q64092478-D6367DAB-1DA9-4C84-A34D-7F9A6318CE0EQ64092483-9590E8AC-49E6-4599-8C64-EF6623EC05F7Q64092487-946C85D5-32B7-474A-9087-024959F3CC6EQ64092491-6214F7A9-5CC4-4805-A289-1AAC6E77AB28Q64092495-46ED6C3F-EF39-439A-87C8-2B1AF4930924Q64092500-380AF1AF-2BA1-476F-AC2B-1037201D9368Q64092504-8578321C-6740-47E7-802B-590BB0B2D114Q64092508-0881412D-6BAA-4029-AA0C-88C130A1E70BQ64092513-FC2C83AC-F7CD-4966-A97D-AC4FFC2A7813Q64092517-C36AC759-BCCF-4FC6-887E-2BED2D7DE7B9Q64092525-B04E1B06-7DDB-4965-B35F-08AF292F6CCFQ64092530-5562C5AF-88C7-496E-A995-F8C7B5D05C8CQ64092534-CF758F9F-5B1F-4893-AC4D-6968AF4813AAQ64092541-9A215E2D-FB8F-4938-840D-C2C7013E49D3Q64092556-D2C92CFA-B6C0-4F8D-BE17-441A8DF3D66CQ64092560-145DA433-2A3E-4387-B565-05B2489C0BD5Q64092565-4DB0C83E-8C52-47A3-AF93-EBAB76A382CBQ64092568-21F042B0-F668-411E-9BA1-A3980C25C70EQ64092573-061207D3-C052-40D1-84AA-C592E79D9D38Q64092575-A3E80FFB-9DA6-4E8F-BAB9-498FC08752A0Q64092579-4B8B3E64-FD12-489E-B06F-0A1DBBDEED0FQ64092583-42C16EF9-1652-4D46-9F1C-07BD43A23EAFQ64092588-F4483EC8-2C9C-4E92-ACE6-263F2256F3F3Q64092591-80B74C41-7141-41EB-83C7-96813665D015Q64092596-FDA26C95-43F5-4609-A910-E23CE55E76C8Q64092598-7CC6F311-96FF-44B1-A792-FBF528E49DAAQ64092603-B6E6C957-322E-4E77-8A7C-8D25B9C318DDQ89413478-999EA324-1941-4E7A-BED8-CBD18FB1018CQ90107028-93E0BFA4-9D9E-4E39-8E83-F5401F9E95AF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thomas Beaney
@ast
Thomas Beaney
@en
Thomas Beaney
@es
Thomas Beaney
@nl
type
label
Thomas Beaney
@ast
Thomas Beaney
@en
Thomas Beaney
@es
Thomas Beaney
@nl
prefLabel
Thomas Beaney
@ast
Thomas Beaney
@en
Thomas Beaney
@es
Thomas Beaney
@nl
P106
P1153
55614780900
P31
P496
0000-0001-9709-7264